Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Limited has disclosed a change in the holdings of its managing director, Philip Daffas, who has increased his direct stake in the company through the issue of 147,059 fully paid ordinary shares, taking his total shareholding to 3,114,226 shares alongside existing options and performance rights. The new shares were issued as part of a placement previously approved by shareholders at the 2025 Annual General Meeting, signalling continued alignment between executive leadership and shareholders’ interests and underscoring board-level participation in the company’s capital-raising activities.
More about PainChek Ltd
PainChek Limited is an Australian-listed company that develops and commercialises technology-based solutions in the healthcare sector, with its core focus on clinically validated tools for pain assessment and monitoring. Its products target medical and aged care settings where accurate, objective measurement of pain is critical for patient management and care quality.
Average Trading Volume: 461,214
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$58.47M
See more insights into PCK stock on TipRanks’ Stock Analysis page.